Rapamycin treatment ameliorates HLA-B27-mediated gut inflammation and alters the microbiome in experimental spondyloarthritis

ObjectiveTo determine whether rapamycin affects HLA-B27-mediated gut inflammation in experimental spondyloarthritis (SpA).MethodsHLA-B27/human β2-microglobulin transgenic (B27-Tg) rats with gut inflammation were treated with rapamycin (1.5 mg/kg intraperitoneally, 3 times a week) or vehicle for 5 we...

Descrición completa

Detalles Bibliográficos

Principais autores:	Jinny Van Doorn, Stephen R. Brooks, Francesca LiCausi, Kelly Zhou, Naga S. Betrapally, Eva Gubitz-Hess, Antony Cougnoux, Stefania Dell’Orso, Shamima Islam, Robert A. Colbert, Fatemeh Navid
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2026-03-01
Series:	Frontiers in Immunology
Assuntos:	gut inflammation HLA-B27 IL-17 rapamycin spondyloarthritis
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1755132/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!